April 19, 2010

Novotech partners with Citeline

Australian based contract research organisation (CRO) Novotech hopes to rapidly accelerate patient recruitment and complete studies more quickly with the application of new tracking technology.

The company says it has entered into a strategic partnership with US based clinical trial intelligence agency Citeline to implement two of the agency’s leading technology platforms TrialTrove and SiteTrove. Novotech CEO Alek Safarian says the partnership fits in well with the company’s mission to bring the best combination of technologies and people to sponsors worldwide.

“As the most comprehensive clinical trial tracking service in the marketplace, our investment in TrialTrove and SiteTrove will bring immense benefit to Novotech and our sponsors in assessing feasibilities and planning new clinical trials in the region,” Mr Safarian said.

By Simone du Toit http://www.trialsinfocus.com/

Other relevant content